by Ernie Mundell Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows. The two drugs are metformin, one of the most widely used diabetes medications, and the GLP-1 class of medications that includes Ozempic, Mounjaro, and Saxenda. A study of nearly 13,000...
Tag: <span>Metformin</span>
Post
Metformin: An Unexpected Ally Against Long COVID?
Metformin use in adults with type 2 diabetes (T2D) is associated with a slightly lower incidence of long COVID and death within 180 days after SARS-CoV-2 infection. METHODOLOGY: TAKEAWAY: IN PRACTICE: “The incidence of PASC was lower when defined by [International Classification of Diseases] code compared with a computable phenotype in both databases,” the authors...
Post
Insulin and metformin combo aids diabetic foot ulcer healing, new study finds
September 4, 2024 by Michigan State University Credit: ACS Pharmacology & Translational Science (2024). DOI: 10.1021/acsptsci.4c00418People with chronic diabetic foot ulcers could soon have a new way to treat their wounds for faster healing and fewer hospital stays. Researchers from Michigan State University and South Shore Hospital have uncovered that the combination of two common...
Post
Study reveals metformin’s role in slowing colorectal cancer cell growth
JUNE 11, 2024 by Flinders University Credit: Cancers (2024). DOI: 10.3390/cancers16112055 Flinders University researchers have analyzed how an antidiabetic treatment could help control the growth of tumors, potentially paving the way for the design of better cancer treatments. The new study investigated what happens when metformin, a type 2 diabetes medication, is used to treat...
Post
What to Know About Taking Vitamin B12 and Metformin
Written by Jennifer Gershman, PharmD, CPh, PACS | Reviewed by Austin Ulrich, PharmD, BCACP Key takeaways: Metformin is a first-choice medication for managing Type 2 diabetes. But it can sometimes lower your vitamin B12 levels.Many foods, dietary supplements, and prescription medications contain vitamin B12 (cobalamin) to some degree. If your vitamin B12 levels get too...
Post
Long-Term Side Effects of Metformin: What Are the Risks?
Written by Timothy Aungst, PharmD | Reviewed by Amy B. Gragnolati, PharmD, BCPS AsiaVision/E+ via Getty Images Key takeaways: Metformin is a common first-choice treatment for Type 2 diabetes. It helps lower your blood sugar levels and can lower your risk of cardiovascular events like heart attacks. It also has a low risk of causing...
Post
More Evidence Metformin May Be Neuroprotective
Megan Brooks October 31, 2023 TOPLINE: New research suggests terminating metformin may raise the risk for dementia in older adults with type 2 diabetes, providing more evidence of metformin’s potential neuroprotective effects. METHODOLOGY: TAKEAWAY: IN PRACTICE: The findings “corroborate the largely consistent evidence from other observational studies showing an association between metformin use and lower dementia incidence...
Post
Study finds metformin can help manage weight gain side effect of bipolar medications
by Tim Tedeschi, University of Cincinnati Credit: Unsplash/CC0 Public Domain A new large-scale study led by researchers at the University of Cincinnati and Northwell Health, New York’s largest health care provider, found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder. The collaborative team presented its findings...
Post
First-Line Therapy in T2D: Has Metformin Been ‘Dethroned’?
Joshua J. Neumiller, PharmD, CDCES; Radica Z. Alicic, MD, MSc DISCLOSURES August 15, 2023Initially approved by the US Food and Drug Administration (FDA) in 1994, metformin has been the preferred first-line glucose-lowering agent for patients with type 2 diabetes (T2D) owing to its effectiveness, low hypoglycemia risk, weight neutrality, long clinical track record of safety,...
Post
First-Line Therapy in T2D: Has Metformin Been ‘Dethroned’?
Joshua J. Neumiller, PharmD, CDCES; Radica Z. Alicic, MD, MSc Initially approved by the US Food and Drug Administration (FDA) in 1994, metformin has been the preferred first-line glucose-lowering agent for patients with type 2 diabetes (T2D) owing to its effectiveness, low hypoglycemia risk, weight neutrality, long clinical track record of safety, and affordability. However,...